ARCHIVES

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

The Lancet Corrects Henschke Letters.

July 18, 2008

Clearinghouse Insists On New Dichlorvos Test; CSWG Disagrees

March 24, 1978

Reports On AACR Scientific Sessions

May 21, 1976

Pitt Cancer Center Director Herberman Issues “Precautionary Advice” On Cell Phone Use.

July 25, 2008

NCAB Removes Its Restrictions On PDQ Access, Permits NCI Staff To Decide

February 7, 1986

Text of Peer Review Of Medenica’s Treatment Of Breast Cancer Patient

April 30, 1993